Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Amortization - GoodwillEBIATLong-Term Debt IssuancesLong-Term Debt RepaymentsReceivables RefundsShares IssuedShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Bruker (BRKRP) Short-Term Debt repayments (2017 - 2025)

Historic Short-Term Debt repayments for Bruker (BRKRP) over the last 10 years, with Q3 2025 value amounting to $574.7 million.

  • Bruker's Short-Term Debt repayments rose 28700.34% to $574.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 180.02%. This contributed to the annual value of $1.2 billion for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Bruker's Short-Term Debt repayments stood at $574.7 million, which was up 28700.34% from $51.2 million recorded in Q2 2025.
  • Bruker's Short-Term Debt repayments' 5-year high stood at $839.6 million during Q2 2024, with a 5-year trough of -$3.8 million in Q1 2023.
  • Its 5-year average for Short-Term Debt repayments is $125.4 million, with a median of $1.4 million in 2022.
  • Its Short-Term Debt repayments has fluctuated over the past 5 years, first plummeted by 42857.14% in 2023, then soared by 3348000.0% in 2025.
  • Bruker's Short-Term Debt repayments (Quarter) stood at -$800000.0 in 2021, then skyrocketed by 387.5% to $2.3 million in 2022, then soared by 391.3% to $11.3 million in 2023, then surged by 1883.19% to $224.1 million in 2024, then surged by 156.45% to $574.7 million in 2025.
  • Its Short-Term Debt repayments stands at $574.7 million for Q3 2025, versus $51.2 million for Q2 2025 and $167.9 million for Q1 2025.